USD 5.19 Billion
Travel Vaccines Market Size, Share, and Growth Analysis
Travel Vaccines Market By Composition (Mono Vaccines, Combination Vaccines), By Administration Route (Injectable Vaccines, Intranasal Vaccines), By Diseases (Hepatitis A, Yellow Fever), By Travel Type (Domestic, Outbound), By Age Group (Infants & Children, Adults), By Region - Industry Forecast 2025-2032
Report ID:
SQMIG35I2375 |
Region:
Global |
Published Date: May, 2025
Pages:
157
|Tables:
147
|Figures:
78
Format -
Travel Vaccines Market Insights
Global Travel Vaccines market size was valued at USD 5.19 Billion in 2023 and is poised to grow from USD 5.74 Billion in 2024 to USD 11.93 Billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).
Growing awareness of health risks, increased travel abroad, and government vaccination programs have helped spark the global travel vaccine market. Infectious diseases, gaining more attention, and advancements made in product delivery and development are the factors contributing towards growth of the market. There are consumer needs for prevention and protection that still fuel innovation.
Factors, such as increased global health awareness and increased understanding and considerations concerning infectious diseases, leading to changes in consumer behavior, have greatly influenced the Travel Vaccines market. With international travel climbing steadily, particularly during the post-pandemic period, there is a significant increase in pre-travel health agenda measures, including vaccinations. Travelers become more aware of health risks and how different regions possible, which in turn has resulted in an increase in travel-specific vaccines for yellow fever, hepatitis A, typhoid, as well as government regulations and the requirement of proof of vaccination for entry into certain countries as a contributing factor. Countries in the emerging economies have experienced tremendous increases in demand for vaccines, especially because their health infrastructure is not entirely developed as citizens and foreign tourists want to keep their health safe.
The Travel Vaccines industry, however, has its own challenges- the foremost being access to vaccines in remote locations or countries. Cold-chain logistics, especially for vaccines requiring refrigeration, remain a major hurdle. Competition within the pharmaceutical sector as well as new methods in vaccine delivery and increased regulatory hurdles are creating a market that is dynamic and sometimes volatile. Although many regulatory bodies are working towards improving the accessibility and safety of vaccines, such as the WHO and the CDC, production costs in most cases, especially of such new vaccines or formulations, tend to limit market profitability for some players. Innovation and collaboration with government, NGO, and private sector companies fuel the growth of this market.
How is the growth in global travel influencing the demand for travel vaccines?
Travel internationally is on an uptick, particularly in the year 2021 and onward, and preventive health interventions like travel vaccines have become a global need. This was corroborated with a 182% increase in international tourist arrivals as endorsed by the United Nations World Tourism Organization (UNWTO) in 2022, showing how freely people are being able to move across continents. This creates a huge demand for getting travelers vaccinated against illness peculiar to various regions. It has also long been felt the need to pursue wide vaccination campaigns against diseases endemic in areas where people tend to travel more-Malaria, Zika, and Dengue.
For example, In 2023, the International Air Transport Association (IATA) reported that international travel had surpassed pre-pandemic levels with a 41.6% increase compared to 2022, further underscoring the increasing demand for health precautions like vaccines, especially among travelers heading to high-risk areas.
Why is there a growing demand for travel vaccines related to health and disease prevention?
The international travel arena has become increasingly aware of the health threats, especially because of the aftermath of COVID-19. The more people become aware of the threats posed by diseases of such as tuberculosis, malaria, and cholera, the more they tend to want a vaccine against them for their own protection. Health agencies are also, including CDC and WHO, trying to create awareness among travelers for vaccinations before traveling to certain areas. This seems to be the evolution now looking towards the preventive side of managing diseases due to the rising mountain of data concerning disease outbreaks and preventive mechanisms.
For instance, the CDC’s Travel Health Notices and updated vaccination guidelines for international travelers have helped improve vaccine uptake, particularly among travelers visiting areas with high disease burden.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Combination Vaccines
Fastest Growth
Combination Vaccines
Growth Rate
9.6% CAGR
Global Travel Vaccines Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Travel Vaccines Market Segments Analysis
The global Travel Vaccines Market is segmented by Composition, Administration Route, Diseases, Travel Type, Age Group and region. Based on Composition, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Administration Route, the market is segmented into Injectable Vaccines, Intranasal Vaccines and Oral Vaccines. Based on Diseases, the market is segmented into Hepatitis A, Yellow Fever, Typhoid, Hepatitis B, Measles & Mumps, Rabies, Influenza and Others. Based on Travel Type, the market is segmented into Domestic and Outbound. Based on Age Group, the market is segmented into Infants & Children, Adults and Elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Why is the Combination Vaccines Segment Leading the Market?
Combination vaccines dominate the travel vaccine market due to their convenience, broad-spectrum protection, and improved compliance. Combination vaccines help reduce the number of injections that travelers will need during a trip and are especially beneficial for travelers who may be going to several high-risk countries. For example, Sanofi pasteur's Typhim Vi and GlaxoSmithKline's Twinrix (Hepatitis A and B combo) are widely disseminated. In 2023, for example, Twinrix saw broad availability in the Asia-Pacific area as a result of increased outbound travelers from that region, particularly to risk areas in Africa and South America.
Mono vaccines( cholera or rabies) have a fast growing market, and have much more availability in the last decade as travelers become aware of distinctive regional disease threats and the need for tailored travel protection according to destination-based risk. Mono vaccines are especially in demand among adventure travelers and rural travelers, as well as travelers going to risk destinations.
What is Driving the Surge in Hepatitis A Vaccines?
Hepatitis A is the leader of the disease segment due to the prevalence of hepatitis A virus around the world and the ability to transmit the virus through contaminated food and water, especially in developing countries. The CDC has recommended vaccination for a nearly every international traveler, especially from areas such as South Asia and Latin America. In March 2023, GSK stated that they had experienced an increase in Havrix (Hepatitis A vaccine) sales because of the resurgence in international travel post pandemic and the continued awareness around food borne illness in international travel.
The yellow fever vaccines are on a fast growth trajectory due to travel to sub-Saharan Africa and South America, where the vaccination is needed. In addition, the 2023 WHO data confirmed heightened demand for vaccine due to more outbreaks, with countries like Brazil expanding access to their vaccine while issuing advisories as travel expanded within their countries, aiding the expansion of this segment.
Global Travel Vaccines Market Analysis by Diseases
To get detailed analysis on other segments, Request For Free Sample Report
Travel Vaccines Market Regional Insights
Why is Demand for Travel Vaccines Fueling Growth in North America?
North America continues to dominate the travel vaccine market, driven by high outbound travel volumes, mandatory immunization policies, and strong public health infrastructure. Growing awareness regarding diseases like yellow fever, typhoid, and meningitis among U.S. and Canadian travelers supports steady vaccine uptake. Government-funded vaccination programs and initiatives like the CDC’s Travelers’ Health division further bolster growth. Strong R&D investments by companies like Pfizer and Sanofi Pasteur also contribute significantly to the market expansion.
U.S. Travel Vaccines Market
The U.S. is a key contributor, supported by high travel frequency and stringent travel health regulations. In 2024, Pfizer announced the expansion of its vaccine portfolio with an updated typhoid conjugate vaccine, aiming to address rising international travel to endemic regions. Additionally, the CDC’s Travelers’ Health Program continues to update vaccine recommendations for global travelers, increasing public compliance.
Canada Travel Vaccines Market
Canada in North America is expanding immensely in the Travel Vaccines market due to increasing government support and public-private healthcare initiatives. In 2024, the Canadian government expanded its “Immunization Partnership Fund” with a new $10 million injection to promote adult immunization, especially targeting travel-related vaccines for diseases like hepatitis A and B. This initiative is expected to enhance vaccine uptake among outbound Canadian travelers.
What Factors are Supporting Growth in Europe Travel Vaccines Market?
Europe remains a significant market due to its high international mobility, strong vaccination culture, and government-supported travel health initiatives. The European Centre for Disease Prevention and Control (ECDC) actively updates travel vaccine guidelines, encouraging pre-travel health consultations. Rising demand for travel to tropical and emerging destinations fuels the need for vaccines against diseases like yellow fever, hepatitis, and rabies. Europe's commitment to vaccine research and manufacturing—led by firms like Sanofi, Valneva, and GlaxoSmithKline—continues to ensure market strength.
Germany Travel Vaccines Market
Germany’s market strength comes from its rigorous health regulations and large volume of international travelers. Germany’s Federal Ministry of Health updated its subsidy program for travel vaccinations, covering a wider range of diseases for travelers to Asia and Africa. German biotech companies, including CureVac, are also exploring mRNA-based vaccines for travel-related infections.
France Travel Vaccines Market
France maintains strong growth, helped by proactive government programs and private-sector participation. In March 2024, Sanofi launched a new awareness campaign promoting yellow fever and hepatitis vaccines for travelers headed to Latin America and Africa. Paris travel clinics have seen a 20% year-on-year increase in vaccination appointments, driven by expanded insurance coverage for preventive care.
Spain Travel Vaccines Market
Spain’s Travel Vaccine market is witnessing growth as outbound tourism recovers and awareness about tropical disease risks rises. Spain’s Ministry of Health partnered with private clinics like Quirónsalud to expand access to pre-travel vaccinations across major urban centers. Growing traveler demand for protection against diseases like dengue, hepatitis, and typhoid is leading to a significant uptick in vaccine uptake, further boosting Spain’s role in the European travel vaccine market.
Why is Asia Pacific the Fastest-Growing Travel Vaccines Market?
Asia Pacific is witnessing rapid growth, driven by increasing international travel, urbanization, and government immunization drives. Rising disposable incomes in Japan, South Korea, and other nations, along with greater awareness of infectious diseases, fuel this trend. Regional vaccine production is expanding, and countries are investing heavily in travel health infrastructure, boosting accessibility and affordability of vaccines.
Japan Travel Vaccines Market
Japan’s market growth is fueled by outbound tourism and increased risk awareness post-pandemic. In February 2024, Takeda Pharmaceuticals launched a new Japanese encephalitis vaccine targeted at international travelers, with a particular focus on Southeast Asia trips. The Japanese Ministry of Health has also intensified awareness campaigns for pre-travel vaccinations, supporting market demand.
South Korea Travel Vaccines Market
South Korea is emerging as a strong player, driven by the sharp rise in international tourism and business travel. SK bioscience is strengthening partnerships to dominate the preventive medicine market, as seen in its expanded 2025 agreement with Sanofi to co-promote and distribute RSV and hepatitis A prevention medicines. Government advisories encouraging vaccinations for African and South American destinations are further propelling market growth.
Global Travel Vaccines Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Travel Vaccines Market Dynamics
Travel Vaccines Market Drivers
Rising International Travel and Regulatory Health Requirements
- The surge in global tourism is a critical driver for the travel vaccine industry. According to the UNWTO, international tourist arrivals reached 1.29 billion in 2023, a sharp rebound from pandemic lows. Countries like Saudi Arabia and Australia now mandate proof of vaccination for diseases like yellow fever for travelers from endemic regions. Pharmaceutical companies like Sanofi reported in their 2023 annual report a 10.4% growth in travel vaccine revenues, highlighting how regulatory health checks are boosting demand.
Emerging Infectious Disease Outbreaks and Public Health Initiatives
- The growing frequency of outbreaks — such as the 2022 Marburg virus cases in Ghana — underscores the need for preventive vaccination among travelers. The CDC and WHO issued urgent travel health advisories, amplifying public awareness. In response, companies like GSK expanded production of vaccines like Rabipur (rabies vaccine), as noted in their 2023 Investor Presentation. Government-backed campaigns, like the U.S. CDC’s Global Health Protection Initiative, have also significantly fueled industry expansion.
Travel Vaccines Market Restraints
High Cost of Travel Vaccines and Limited Insurance Coverage
- Travel vaccines often come with high out-of-pocket expenses, discouraging uptake. The CDC reported in 2023 that common travel vaccines like yellow fever and typhoid can cost between $150–$350 per dose, with most insurance plans excluding them. Companies like Emergent BioSolutions acknowledged in their 2023 Annual Report that vaccine affordability remains a barrier to wider market penetration, particularly among budget-conscious travelers in emerging economies.
Vaccine Supply Shortages and Manufacturing Challenges
- Global vaccine shortages, particularly for yellow fever and rabies, have constrained market growth. Sanofi publicly noted in its Investor Update that production disruptions at its Marcy-l'Étoile facility led to limited supply of Stamaril (yellow fever vaccine) across several regions. WHO's 2023 health bulletins also flagged multiple supply bottlenecks, exacerbated by complex cold-chain requirements, highlighting the fragile nature of vaccine availability in the travel sector.
Request Free Customization of this report to help us to meet your business objectives.
Travel Vaccines Market Competitive Landscape
To stay competitive in the travel vaccine market, companies are leveraging AI-driven epidemiological analytics, cloud-based health platforms, and precision manufacturing. Strategic collaborations with governments and NGOs accelerate vaccine distribution and innovation. Emphasis on regulatory compliance and region-specific vaccine customization addresses evolving travel mandates. Real-time disease surveillance enhances responsiveness, enabling brands to anticipate outbreaks, ensure supply continuity, and meet the diverse health needs of global travelers in an increasingly dynamic environment.
Top Player’s Company Profiles
- Pfizer
- Sanofi
- GlaxoSmithKline
- Merck & Co., Inc.
- AstraZeneca
- Abbott Laboratories
- F. Hoffmann-La Roche AG
- Takeda Pharmaceutical
- VBI Vaccine Inc.
- Bavarian Nordic
- CSL
- Valneva SE
- Johnson & Johnson Services Inc. (Crucell)
- Dynavax Technologies
- Novartis AG
- Bharat Biotech
- Emergent BioSolutions
- Hualan Biological Engineering Inc.
- Serum Institute of India Pvt. Ltd.
- Zydus Group
Recent Developments in Travel Vaccines
- Valneva SE announced the approval of its single-dose chikungunya vaccine, IXCHIQ®, for European adolescents in April 2025, expanding protection against the mosquito-borne disease. Already approved in the U.S., Canada, and the U.K. for adults, IXCHIQ® is now authorized in the EU, Norway, Liechtenstein, and Iceland for individuals aged 12 and above. The vaccine addresses the rising global spread of chikungunya and supports accelerated approvals in other endemic regions.
- On March 31, 2025, CEPI announced up to $13.38 million in funding for Gennova Biopharmaceuticals to advance a self-amplifying mRNA (saRNA) vaccine candidate for Nipah virus. This innovative vaccine, developed in collaboration with Houston Methodist Research Institute, aims to protect against the deadly virus, with Phase 1 studies planned. CEPI’s ongoing commitment of over $100 million supports global efforts to combat Nipah and potential future threats like Disease X..
- On March 31, 2025, CEPI announced a funding commitment of up to $13.38 million to Gennova Biopharmaceuticals for advancing its self-amplifying mRNA (saRNA) vaccine candidate for Nipah virus. Developed in partnership with Houston Methodist Research Institute, the vaccine aims to protect against the deadly pathogen. CEPI’s funding supports Phase 1 studies and global efforts to tackle Nipah and other emerging threats like Disease X.
Travel Vaccines Key Market Trends
Emerging Trends Shaping the Future of Travel Vaccines
- Short-Term: The travel vaccine market is witnessing a surge in demand for COVID-19 booster doses. As countries continue to require updated vaccinations for international travel, pharmaceutical companies like Pfizer and Moderna are responding by ramping up production. In 2024, sales of boosters are expected to grow by 15-20%, driven by countries like the U.S. and EU enforcing vaccination regulations. For instance, the CDC maintains guidelines emphasizing booster shots for travelers heading to high-risk areas.
- Mid-Term: The integration of digital health passports is becoming a significant trend, facilitating smoother international travel. The IATA Travel Pass and CommonPass are becoming critical tools for verifying vaccination status. By 2025, 80% of international travelers are expected to use digital vaccination credentials, driven by major airlines like Qatar Airways adopting these systems to streamline travel and health verification. This shift is transforming how vaccines are tracked and integrated into the travel experience.
- Long-Term: The future of travel vaccines lies in personalized health plans, tailored to the specific needs of individual travelers. By 2030, travel vaccines are expected to be integrated with personalized health data, with companies like Cigna already exploring genetic profiling for travelers. This will ensure that vaccines are not only suited to the destination but also to the traveler’s health history and genetic makeup, revolutionizing how travel health is managed across the globe.
Travel Vaccines Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global Travel Vaccines market is set to experience robust growth, driven by the increasing volume of international travel and rising health awareness among travelers. Regulatory requirements for vaccines, particularly for high-risk destinations, are fueling demand. Technological advancements, such as digital health passports, and the focus on personalized health plans are also contributing to market expansion. However, challenges such as vaccine affordability, supply chain disruptions, and regional disparities in access remain. Leading pharmaceutical companies are investing in innovations and partnerships to address these challenges and cater to the evolving needs of global travelers.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 5.19 Billion |
| Market size value in 2032 | USD 11.93 Billion |
| Growth Rate | 9.6% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Travel Vaccines Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Travel Vaccines Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Travel Vaccines Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Travel Vaccines Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Travel Vaccines Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Travel Vaccines Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Travel Vaccines Market Report Snapshots
REQUEST FOR SAMPLE
Want to customize this report?
REQUEST FREE CUSTOMIZATION
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
